• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Varian takes out CyberHeart

Share:

May 13, 2019

Varian has acquired privately held CyberHeart, a developer of a non-invasive treatment called radioablation for cardiac arrhythmias.

Financial terms are not disclosed.

Date: May 13, 2019

Source: Seeking Alpha

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19
  • A 4.5% Rise in Demand for Pregnancy Point of Care Testing Products Expected By 2028A 4.5% Rise in Demand for Pregnancy Point of Care Testing Products Expected By 2028
  • Evidation Health Nabs $153M to Expand Virtual Health ProgramsEvidation Health Nabs $153M to Expand Virtual Health Programs
  • Endoscopic AI Maker AI Medical Service Scores $70M in Series C FundingEndoscopic AI Maker AI Medical Service Scores $70M in Series C Funding
  • AIA Thailand Partners with True Digital Group and Samitivej to Launch Virtual COVID-19 ClinicAIA Thailand Partners with True Digital Group and Samitivej to Launch Virtual COVID-19 Clinic
  • Device Cybersecurity: For Better — and Worse? The Very Connected World of Medical DevicesDevice Cybersecurity: For Better — and Worse? The Very Connected World of Medical Devices
  • BioLife Solutions Strengthens Gene Therapy Capabilities with $24 Million AcquisitionBioLife Solutions Strengthens Gene Therapy Capabilities with $24 Million Acquisition
  • Bayer wins EU approval for $62.5 billion Monsanto buyBayer wins EU approval for $62.5 billion Monsanto buy

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications